Tepezza Hearing Loss Lawsuits

Lawyers are now filing claims against the maker of the eye medication Tepezza on behalf of those who suffered hearing loss after using the drug.

  • Fast and easy case evaluation
  • Help available in all 50 states
  • No costs to file a case unless you win
  • Speak with an attorney today.

Victims may be entitled to substantial compensation for a limited time. Some of the hearing loss conditions linked to Tepezza include:

  • Subjective hearing loss
  • Tinnitus (ringing in the ears)
  • Ear plugging sensation
  • Autophony (hearing your own voice loud).
LEARN MORE ABOUT YOUR RIGHTS

Free Case Review

Our attorneys have helped thousands of victims fight dangerous pharmaceuticals. "The free evaluation is always confidential."

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Tepezza, also known asTeprotumumab, is an IV infusion drug prescribed to adults with thyroid eye disease (TED), a rare condition where the eyes bulge outward from inflammation in the muscles and fatty tissues behind the eye.

tepezza hearing loss lawsuit

Tepezza Hearing Loss

TED can cause a number of complications such as eye pain, double vision, light sensitivity or difficulty closing the eye that often inhibit the ability to drive or work.

Tepezza was the first-ever medication approved by the FDA for the treatment of TED, and as a result it received Fast Track, Priority Review and Breakthrough Therapy Designation by the agency. Perhaps due to this, the side effects on patients weren’t fully disclosed.

Although Horizon Pharma initially reported minimal hearing loss side effects in only 10% of users from its own clinical trials, experts now warn that Tepezza patients may have a significantly higher risk of hearing loss from the drug.

A 2021 Stanford University study revealed that a staggering 65% of patients receiving Tepezza reported hearing loss, most after just three treatments. Hearing problems included:

  • Subjective hearing loss
  • Tinnitus (ringing in the ears)
  • Ear plugging sensation
  • Autophony (hearing your own voice loud).

Due to the failure of Horizon Pharma to warn patients of the hearing loss injuries linked to Tepezza, lawyers believe the company will be liable for substantial damages to those affected. They’ve begun filing Tepezza lawsuits on behalf of anyone who suffered hearing loss of changes after taking the drug.

Do I Qualify for a Tepezza Lawsuit?

Horizon Pharma is a company with over $3 billion in annual revenue that is trying to finalize a sale to industry giant Amgen for nearly $30 billion. Their flagship drug Tepezza represents around half of their yearly sales. 

Some legal experts question whether the company tried to conceal the dangers of Tepezza in order to save this lucrative sale of the company.  

Now, Horizon and Amgen face a growing number of lawsuits in the United States from patients with hearing loss who weren’t warned of the dangers. 

If you or a loved one were administered Tepezza and later suffered hearing loss, you may qualify to file a lawsuit for medical, financial and pain & suffering compensation. 

Those who suffered any of the following may be eligible to file a claim:

  • Subjective hearing loss
  • Tinnitus (ringing in the ears)
  • Ear plugging sensation
  • Autophony (hearing your own voice loud).

Lawyers are urging anyone affected to learn about their legal options as soon as possible, since the time to file a claim will eventually expire. Some of the factors your lawyer will rely on to construct a case include:

  • When did you first use Tepezza?
  • How many treatments did you receive?
  • What type of hearing problems have you experienced?
  • Have you seen a hearing doctor or been diagnosed?

It costs nothing to speak with a lawyer or file a claim, and the total litigation process could take a year or more. Contact DrugNews today to discuss your case directly with a lawyer.

Free Case Review

Tepezza Lawsuit Timeline

Latest Information on the Tepezza hearing loss litigation.

2022
Dec
Lawyers file motion to consolidate Tepezza hearing loss lawsuits to the multidistrict litigation court in the Northern District of Illinois.
2022
Aug
Daniel Weibel files the first Tepezza lawsuit in Illinois federal court alleging the drug caused permanent hearing loss after just three months of use.
2022
Feb
Horizon Pharma adds hearing loss to list of Tepezza side effects.
2021
Mar
Stanford study highlights increased risk of hearing loss among patients using Tepezza.
2020
Jan 23
NEJM reports second Horizon Pharma Tepezza clinical trial of 83 patients indicating only 10% suffered hearing loss.
2020
Jan 21
FDA approves Tepezza as first-ever medication for Thyroid Eye Disease.
2017
Feb
Horizon Pharma completes clinical trial of Tepezza with 88 patients reporting only 10% suffered hearing loss.
2009
Tepezza compound teprotumumabis first studied by Roche Pharmaceuticals for the treatment of breast cancer, Hodgkin's and non-Hodgkin's lymphoma, and lung cancer.

Is There a Tepezza Class Action Lawsuit?

While there is no single Tepezza hearing loss class action lawsuit, lawyers are requesting that a special federal court be established that will provide greater access to justice for the potential thousands of individual victims.

In late 2022, lawyers representing a group of victims asked that Tepezza hearing loss lawsuits be consolidated into a federal multidistrict litigation (MDL) court in Northern Illinois. 

This type of specialized court will be more beneficial to victims than a Tepezza Class Action Lawsuit. In a class action, one group of lawyers usually gathers class participants, who must then share whatever is awarded. 

However, in an MDL court, individual victims are able to share valuable medical evidence while maintaining the ability to select their own lawyer, exercise more control over their case and whether it settles, and reap higher award amounts for their separate lawsuit.  

With the potential for over 5,000 claims, lawyers expect some Tepezza lawsuits will proceed to trial in front of a jury. This could pave the way for others to avoid litigation and take part in a larger settlement program from the company. 

DrugNews works only with lawyers that are integrally involved in the Tepezza litigation and have handled thousands of drug injury and hearing loss lawsuits.

Choosing a Tepezza Lawyer

If you or a loved one developed hearing problems after being administered the drug Tepezza, it’s important to have a lawyer investigate your case to see if you have the right to recover damages.   

Our qualified drug injury lawyers will fully examine your case, reviewing medical records and drug safety research that your doctor may not normally discuss.  

Product injury laws may allow between two to four years from the date of injury for victims and their families to file claims. However, you should begin the process as early as possible to make sure your lawyer has time to get necessary records and prepare your case.  

DrugNews works only with attorneys and law firms that have successfully handled tens of thousands of lawsuits involving injury or death from harmful drugs and defective products. And, we’ll connect you directly to a lawyer or patient advocate today, so you’ll be able to decide if you want to proceed.  

We make it easy to get help, find out if you qualify, and quickly file a claim. Our service is offered at no cost to you, and you won’t pay anything to your attorney unless you receive an award. Also, our qualified lawyers can handle most aspects of your case without you ever leaving your home.  

For more information, or to learn about your options - call, chat or email us today.

Do you have a case?

Speak with a lawyer who specializes in the Tepezza litigation.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Sources of information

Get in touch with us.

Call, email or live chat with us today to see how we can help.

call DrugNews.net
Need a quick answer? Call us!
email DrugNews.net
Reach out to us by email.
live chat with DrugNews
We are here to help now